Page last updated: 2024-10-24

cefuroxime and Mast Cell Activation Disease

cefuroxime has been researched along with Mast Cell Activation Disease in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Research Excerpts

ExcerptRelevanceReference
"Mastocytosis is a heterogeneous group of diseases characterized by excessive proliferation and accumulation of mast cells--in one or more organs."1.42[Anaphylaxis as part of a clinical diagnosis of mastocytosi - case demonstration]. ( Czarnobilska, E; Sacha, M; Stobiecki, M, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stobiecki, M1
Sacha, M1
Czarnobilska, E1

Other Studies

1 other study available for cefuroxime and Mast Cell Activation Disease

ArticleYear
[Anaphylaxis as part of a clinical diagnosis of mastocytosi - case demonstration].
    Przeglad lekarski, 2015, Volume: 72, Issue:12

    Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Cefuroxime; Drug Hypersensitivity; Fema

2015